| Financial Year |
March 31 2023 |
| Monetary Funds |
900,340,439.49 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
1,358,508,250.92 |
| Advances to Suppliers |
435,598,830.08 |
| Other Receivables |
254,416,724.08 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
602,093,255.41 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
183,017,535.48 |
| Total Current Assets |
3,733,975,035.46 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
74,193,746.46 |
| Investment Properties |
42,483,149.78 |
| Fixed Assetes |
535,169,100.00 |
| Under-construction Projects |
321,025,340.87 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
166,456,649.45 |
| R&D expenses |
-- |
| Goodwill |
1,419,875,023.80 |
| Long-Term Deferred and Prepaid Expenses |
183,321,248.01 |
| Deferred Income Tax Assets |
59,677,855.36 |
| Other Non-Current Assets |
62,687,857.58 |
| Sub-Total of Non-Current Assets |
3,086,890,071.51 |
| Total Assets |
6,820,865,106.97 |
| Short-Term Loans |
818,516,972.35 |
| Trading Financial liabilities |
-- |
| Notes Payable |
20,000,000.00 |
| Accounts Payable |
218,974,189.57 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
30,278,769.06 |
| Taxes Payable |
150,210,016.75 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
225,573,944.33 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
33,171,136.37 |
| Other Current Liabilities |
5,951,099.93 |
| Sub-Total of Current Liabilities |
1,558,645,282.94 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
70,000.00 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
54,779,945.30 |
| Total Liabilities |
1,613,425,228.24 |
| Paid-In Capital(Or Share Stock) |
911,411,737.00 |
| Capital Surplus |
5,070,586,680.68 |
| Surplus Reserve |
69,931,642.59 |
| LESS:Treasury Stock |
92,054,726.52 |
| Undistributed Profits |
-761,069,929.28 |
| Minority Stockholder's Interest |
35,436,319.98 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,172,003,558.75 |
| Owner's Equity（Stockholder's Equity） |
5,207,439,878.73 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,820,865,106.97 |
